G E. Ghanem
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
Journal: BMC cancer
Published: January 09, 2025
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy.
Journal: Cancer cell international
Published: July 30, 2023
Corrigendum to 'p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib'[Eur J of Cancer 55 (2016) 98-110].
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 27, 2022
Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.
Journal: Frontiers in oncology
Published: October 22, 2021
Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis.
Journal: Cancers
Published: May 15, 2021
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Journal: Molecular cancer research : MCR
Published: December 09, 2020
Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms.
Journal: Biology
Published: June 23, 2020
Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.
Journal: Nature cell biology
Published: July 22, 2019
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors.
Journal: Nature cancer
Published: June 12, 2019
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.
Journal: Cancers
Published: March 19, 2019
Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas.
Journal: International journal of molecular sciences
Published: November 15, 2017
PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies.
Journal: Cancers
Published: November 01, 2017
Last Updated: 09/26/2026